Purchase Order 75N95024P00366
Award Date 6/28/24
Potential Completion Date 8/28/24
Potential Value $27K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hicksville, NY 11802, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $18,166 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Bioivt, LLC, a for-profit limited liability company, for the delivery of human and mouse hepatopac plates. The contract has a period of performance through November 2, 2024 and was not set aside for any particular business type. Bioivt is a leading global provider of biological specimens and has supported medical research programs across various...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,262.29 contract is for the delivery of primary human hepatocytes, which are a critical reagent used in biomedical research supported by NCATS. This contract is not associated with any set-aside...
- This is a firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the Department of Health and Human Services (HHS), to Mimetas Operations US, Co., a foreign-owned, self-certified small disadvantaged business. The $150,480.00 contract is for the acquisition of Organoplate Grafts, which are microfluidic 3D cell culture plates used in scientific research projects related to SARS-CoV-2 and COVID-19. This contract was...
- This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Life Technologies Corporation for the delivery of 50 vials of human spheroid-qualified hepatocytes. As described in the original solicitation, these liver cells will support the National Institute on Drug Abuse's Antiviral Program for Pandemics by enabling the continued identification of direct-acting antivirals and development of microphysiological systems...
- This is a firm-fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Mimetas Operations US, CO. for 25 units of the Organoplate Graft (part number 6401-400-B), a microfluidic 3D cell culture plate used in research related to SARS-CoV-2 and COVID-19. The $29,075.00 contract was awarded on a sole-source, non-competitive basis due to...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $45,717 firm fixed price purchase order to Xenotech LLC, doing business as Sekisui-Xenotech, for the provision of cryopreserved human, mouse, and rat hepatocytes. The solicitation sought these hepatocytes for use in drug metabolism experiments to support the National Institute on Drug Abuse's malaria research project and understand drug metabolism in...
- This is a non-competitive purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Biosurfaces Inc. for 72 units of 96-well transwell plate assemblies with proprietary biodegradable membrane inserts, along with shipping. The $90,000 firm fixed-price contract is intended to support ongoing COVID-19 research at NCATS, which has an established need for these specialized plates from this vendor. Biosurfaces is a...
- This is a $168,400.00 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Biosurfaces Inc., a for-profit organization. The contract is for the acquisition of 96-well transwell plates with proprietary bio-spun membrane inserts. This is a non-competitive award to support NCATS' ongoing use of this manufacturer's specialized cell culture products. The solicitation indicated the...
- <p>This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian federal agency, to Edition Eight, LLC for the procurement of custom microplates. The contract has a ceiling value of $77,446.52 and a completion date of October 30, 2021. The contract was awarded on May 12, 2021 and does not utilize any set-aside designation. This contract is not associated with a larger contract vehicle.</p>
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) to Bioivt, LLC, a leading provider of biological specimens and services. The $183,092 contract is for a Transporter Substrate Assessment Study to support the development of a novel drug candidate. The study will characterize the metabolic profile and interaction potential of the drug candidate, following FDA guidance. This requirement was competitively solicited under the authority of FAR Part 12 and...